TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways MA Rivas, RP Carnevale, CJ Proietti, C Rosemblit, W Beguelin, ... Experimental cell research 314 (3), 509-529, 2008 | 207 | 2008 |
Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak-and Src-dependent mechanism in breast cancer cells C Proietti, M Salatino, C Rosemblit, R Carnevale, A Pecci, AR Kornblihtt, ... Molecular and cellular biology 25 (12), 4826-4840, 2005 | 169 | 2005 |
Progestin Effects on Breast Cancer Cell Proliferation, Proteases Activation, and in Vivo Development of Metastatic Phenotype All Depend on Progesterone … RP Carnevale, CJ Proietti, M Salatino, A Urtreger, G Peluffo, DP Edwards, ... Molecular endocrinology 21 (6), 1335-1358, 2007 | 127 | 2007 |
TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer MF Mercogliano, M De Martino, L Venturutti, MA Rivas, CJ Proietti, ... Clinical Cancer Research 23 (3), 636-648, 2017 | 117 | 2017 |
Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3 W Béguelin, MCD Flaqué, CJ Proietti, F Cayrol, MA Rivas, M Tkach, ... Molecular and cellular biology 30 (23), 5456-5472, 2010 | 116 | 2010 |
Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in … L Labriola, M Salatino, CJ Proietti, A Pecci, OA Coso, AR Kornblihtt, ... Molecular and cellular biology 23 (3), 1095-1111, 2003 | 111 | 2003 |
p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth M Tkach, C Rosemblit, MA Rivas, CJ Proietti, MCD Flaqué, ... Endocrine-related cancer 20 (2), 197-212, 2013 | 102 | 2013 |
Tamoxifen resistance in breast cancer is regulated by the EZH2-ERα-GREB1 transcriptional axis Y Wu, Z Zhang, ME Cenciarini, CJ Proietti, MF Amasino, T Hong, M Yang, ... Cancer research, canres. 1327.2017, 2017 | 100 | 2017 |
MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1 L Venturutti, RIC Russo, MA Rivas, MF Mercogliano, F Izzo, RH Oakley, ... Oncogene 35 (48), 6189-6202, 2016 | 90 | 2016 |
Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and … M Salatino, R Schillaci, CJ Proietti, R Carnevale, I Frahm, AA Molinolo, ... Oncogene 23 (30), 5161-5174, 2004 | 87 | 2004 |
Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis L Venturutti, LV Romero, AJ Urtreger, MF Chervo, RIC Russo, ... Oncogene 35 (17), 2208-2222, 2016 | 76 | 2016 |
Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth CJ Proietti, C Rosemblit, W Beguelin, MA Rivas, MCD Flaqué, ... Molecular and cellular biology 29 (5), 1249-1265, 2009 | 73 | 2009 |
Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth CJ Proietti Anastasi, C Rosemblit, W Beguelin, MA Rivas, MC Díaz Flaqué, ... American Society for Microbiology, 2009 | 73* | 2009 |
Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance RIC Russo, W Béguelin, MCD Flaqué, CJ Proietti, L Venturutti, ... Oncogene 34 (26), 3413-3428, 2015 | 62 | 2015 |
Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation M Salatino, W Beguelin, MG Peters, R Carnevale, CJ Proietti, ... Oncogene 25 (59), 7723-7739, 2006 | 62 | 2006 |
Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells M Tkach, L Coria, C Rosemblit, MA Rivas, CJ Proietti, MCD Flaqué, ... The Journal of Immunology 189 (3), 1162-1172, 2012 | 55 | 2012 |
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer … MCD Flaqué, NM Galigniana, W Béguelin, R Vicario, CJ Proietti, ... Breast Cancer Research 15 (6), R118, 2013 | 46 | 2013 |
Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated … R Schillaci, M Salatino, J Cassataro, CJ Proietti, GH Giambartolomei, ... The Journal of Immunology 176 (6), 3426-3437, 2006 | 46 | 2006 |
Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer R Schillaci, P Guzmán, F Cayrol, W Beguelin, MCD Flaqué, CJ Proietti, ... BMC cancer 12 (1), 74, 2012 | 45 | 2012 |
Transactivation of ErbB-2 induced by tumor necrosis factor α promotes NF-κB activation and breast cancer cell proliferation MA Rivas, M Tkach, W Beguelin, CJ Proietti, C Rosemblit, EH Charreau, ... Breast cancer research and treatment 122 (1), 111-124, 2010 | 43 | 2010 |